NASHVILLE: HCA Healthcare Inc. (NYSE: HCA) reported higher-than-expected second quarter results Thursday, citing strong revenue growth, margin improvements and higher patient outcomes.
The company’s revenue for the quarter ended June 30, 2025, rose 6.4% to $18.61 billion, while net income attributable to HCA jumped 13.1% year-over-year to $1.65 billion, or $6.83 per diluted share. Adjusted earnings per share climbed 24.4% to $6.84.
Adjusted EBITDA increased 8.4% to $3.85 billion, and operating cash flows more than doubled to $4.21 billion. Same facility admissions rose 1.8%, and revenue per equivalent admission gained 4.0%.
“We are pleased to report strong financial results for the second quarter,” said CEO Sam Hazen. “They reflected solid revenue growth, improved margins, and better outcomes for our patients.”
Capital expenditures totaled $1.18 billion for the quarter, excluding acquisitions. HCA repurchased 7.03 million shares for $2.51 billion and declared a quarterly dividend of $0.72 per share, payable Sept. 30.
The company also raised its full-year guidance. HCA now expects 2025 revenue between $74.0 billion and $76.0 billion, and net income from $6.11 billion to $6.48 billion. Adjusted EBITDA is forecast to land between $14.7 billion and $15.3 billion.
HCA’s outlook assumes stable operating trends and includes estimated impacts from recent hurricanes, inflation, and evolving healthcare policies.